HeartbeamBEAT
Market Cap: $61.4M
About: HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
Employees: 15
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
25% more capital invested
Capital invested by funds: $4.48M [Q1] → $5.59M (+$1.11M) [Q2]
8% more funds holding
Funds holding: 26 [Q1] → 28 (+2) [Q2]
0.46% more ownership
Funds ownership: 7.8% [Q1] → 8.26% (+0.46%) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Benchmark Bill Sutherland 63% 1-year accuracy 31 / 49 met price target | 246%upside $8 | Speculative Buy Reiterated | 4 Sept 2024 |